A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection

BACKGROUND: Sorafenib was reported as a useful adjuvant treatment in patients with hepatocellular carcinoma who underwent surgical resection. However, its therapeutic value remains controversial. This meta-analysis examined the available data regarding the efficacy and safety of sorafenib in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shenglan, Li, Dan, Zhuang, LingLing, Sun, Liying, Wu, Jianbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194151/
https://www.ncbi.nlm.nih.gov/pubmed/34112190
http://dx.doi.org/10.1186/s12957-021-02280-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194151/
https://www.ncbi.nlm.nih.gov/pubmed/34112190
http://dx.doi.org/10.1186/s12957-021-02280-9

Ejemplares similares